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Transfusion Transmitted Hepatitis B Virus among Multitransfused Thalassaemic Children in a Tertiary Health Care
Centre in Bangladesh geographical region. The second commonest cause of death in thalassaemic patients is liver disease due to blood borne viral hepatitis. 1 Children with β thalassaemia and Hb E β thalassaemia are dependent on regular blood transfusions. 2 This is a well-established method of transfusion of HBV and it is well known that exposure to blood and blood products is a risk factor of such virus. Despite the existence of effective vaccine for HBV for the last two decades, the initial strategy for vaccination which targeted the high risk groups including IV drug users was ineffective. 3 The emergence of newly identified hepatitis B viral variance that was found to be resistant to lamivudine and not easily prevented by the widely used recombinant viral vaccine added more complexity and confusion. 4 Though the risk of transmission of HBV has decreased substantially in developed countries with the introduction of pretransfusion screening program, this is still a health hazard in developing countries. Studies among thalassaemic children in different countries showed the prevalence rate of transmission of HBV ranging from 0.53% to 4.5%. 5 In One hundred and fifteen children were included in this study. Among them 68 were β thalassaemic, 27 were Hb E β thalassaemic and 20 were controls. The mean ages in years of β thalassaemic and Hb E β thalassaemic children were 6.8 ± 2.84 and 8.78 ± 2.99 respectively. The mean age of controls was 6.23 ± 1.88. The male to female ratio was 4.2:1 in β thalassaemic and 1.4:1 in Hb E β thalassaemic children. The male to female ratio of controls was 1:2.3. 26 β thalassaemic and 3 Hb E β thalassaemic children were transfused monthly and 42 β thalassaemic and 24 Hb E β thalassaemic children received 2-6 monthly transfusions. 4 β thalassaemic children had been transfused for less than one year, 49 for 1 to 5 years and 15 for more than 5 years. 14 Hb E β thalassaemic children had received transfusions for 1 to 5 years and 13 for more than 5 years. 
Results
Discussion
The survival rates of children with thalassaemia and other chronic haemolytic anaemias have improved with the development of thalassaemia clinics and centres. These children require multiple transfusions and iron chelation and are at increased risk of viral transmitted infection.
Bangladesh is a developing country where HBV i n fection is prevalent. Akbar et al demonstrated a prevalence of HBV infection ranging from 19% to 29% among professional donors and 2 to 4% among voluntary donors. 6 WHO also ranked Bangladesh in the moderate to high risk group countries for HBV infections. Repeated blood transfusions, the main life line support for thalassaemic children, are provided mainly by professional donors in our country. 8 In our study, 22.1% of thalassaemic children were HBsAg positive. This result is lower than that reported by Banarjee from India. He observed 25.9% HBsAg positive cases among multitransfused thalassaemic children. This comparatively low prevalence rate in our observation might be due to introduction a n d implementation of 'Safe blood transfusion 2002', a nationwide blood screening programme in 97 centres throughout the country and awareness among the parents of thalassaemic children about HBV vaccination and active immunization against HBV. 9 But the result of our observation is higher than that reported from other countries, where this ranged from 0.53% to 3.5%. 5 Studies conducted in early 1990s in India showed a much higher prevalence of HBsAg ranging from 22% to 45%. 10 The differences in the results may be due to various factors such as (1) the sensitivity of ELISA, (2) the absence of HBsAg during the window phase and the convalescent phase, (3) very low levels of viremia, (4) effectiveness of screening programmes of blood and (5) the immune status o f r e cipient of multiple transfusions. 11 In our observation we found none of the healthy controls was positive for HBsAg and there is a significant difference (p=0.033) between the diseased children and the controls in respect to HBsAg positivity.
We found anti-HBc total IgM and IgG more often among the thalassaemic children than among controls (p=0.022). Positive anti-HBc total IgM and IgG indicates an HBV infection. 12 This is the most valuable single serological marker in diagnosing HBV infection even when HBsAg remains negative. 13 Although none of the controls was positive for HBeAg in our study, this χ 2 p value marker was found in 4 thalassaemic HBsAg positive children. That did not differ significantly between the thalassaemics and the controls (p=0.637). This result is consistent with that of the another study. 7 On the other hand, 2 of the controls were positive for anti-HBe and all of the thalassaemics were negative. The difference was statistically significant (p=0.008). The reason for this is not known. Unlike our study, Alsheyyab et al reported 3.5% HBeAg and 22% anti-HBe positivity among Arabian children suffering from hereditary haemolytic anemia. 5 Positive HBeAg indicates that the virus replicates, encodes and infects liver cells when it remains highly infectious. 14 On the other hand anti-HBe antibody indicates seroconversion and appearance of anti-HBe is a strong evidence that the patient will recover. 15 As the thalassaemic children are dependent on blood transfusion mostly from professional donors, they can be infected with HBV as the professional donors harbour HBV more often than voluntary donors. 7 In our study, one of the thalassaemic children had both HBV a n d HCV i n fections. Concomitant infection of both HBV and HCV has ominous impact in the pathogenesis of chronic viral hepatitis 16 , leading to rapid progression towards cirrhosis of liver (hepatitis C-global prevalence, 2000). So, HBV vaccination should be considered for the thalassaemic children as a preventive measure. Considering the fatal outcome of concomitant HBV and HCV infection, it is mandatory to transfuse blood which is screened strictly before transfusion, and transfusion of infected blood must be stopped.
In our observation, it revealed that the prevalence rate of hepatitis B viral marker positivity increased with the increment of the number of transfusions. Among the thalassaemic children who were transfused more than 10 times, 57.14% were positive for HBsAg and 42.86% were anti-HBc positive. On the other hand, 14.29% and 17.86% of the diseased children who were transfused 4 times were positive for HBsAg and anti-HBc respectively. It was evident that all of the HBsAg positive thalassaemic children were transfused with blood from the professional donors. This indicates that the professional donors in comparison to the voluntary donors play the major role in transmitting transfusion related HBV with a statistical significance (p=0.021).
Akbar et al demonstrated a prevalence of HBV infection ranging from 19% to 29% among the professional donors and 2 to 4% among the voluntary donors. 6 The WHO also ranked Bangladesh in the moderate to high risk group countries for HBV infections. 17 A significantly higher sero-prevalence of hepatitis B viral marker was observed among the multitransfused thalassaemic children. Since these children depend mostly on professional donors for transfusion, there always remains a possibility of acquiring these infections through blood transfusion.
We acknowledge the potential limitation of our study. The sample size was not sufficiently large. Study subjects were not cohort, collected from the urban set-ups and were not randomly selected. We, therefore, suggest that a multi-centre study should be conducted with a larger sample size from a wider geographic area to reach a firm conclusion on the potential risks of transfusion-transmitted infections among multitransfused thalassaemic children.
